Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/7/24 17:30 | 11/5/24 | CGEM | Health | BioPrd | Biological Products, (No Diag | Michaelson Jennifer | MA | O | Chief Sc | 7 | S.dm | -2,217 | 24.62 | 0 | -90 | 130 | D | |||||||||||||||
2/2/24 21:35 | 2/1/24 | CGEM | Health | BioPrd | Biological Products, (No Diag | Savill Corrine | MA | O | Chief Bu | 3 | S.dm | -1,703 | 14.19 | 0 | -120 | 166 | D | |||||||||||||||
12/27/23 18:30 | 12/26/23 | CGEM | Health | BioPrd | Biological Products, (No Diag | Ahmed Nadim | MA | DO | P,CEO | 1 | S | -39 | 9.24 | 0 | -4 | 112 | D | |||||||||||||||
12/22/23 17:30 | 12/21/23 | CGEM | Health | BioPrd | Biological Products, (No Diag | Jones Jeffrey Alan | MA | O | Chief Me | 2 | S | -19 | 8.45 | 0 | -2 | 58 | D | |||||||||||||||
12/22/23 17:30 | 12/21/23 | CGEM | Health | BioPrd | Biological Products, (No Diag | Sumer Jacquelyn L | MA | O | GC | 2 | S | -14 | 8.45 | 0 | -2 | 46 | D | |||||||||||||||
12/22/23 17:30 | 12/21/23 | CGEM | Health | BioPrd | Biological Products, (No Diag | Trigilio Jeffrey | MA | O | CFO | 3 | S | -35 | 8.16 | 0 | -4 | 86 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |